All influenza vaccines marketed in the UK for the 2025 to 2026 season (text version)
Updated 6 June 2025
© Crown copyright 2025
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/influenza-vaccines-marketed-in-the-uk/all-influenza-vaccines-marketed-in-the-uk-for-the-2025-to-2026-season-text-version
| Supplier | Product | Vaccine type [footnote 1] | Age indications | Ovalbumin content micrograms/dose | Contact details |
|---|---|---|---|---|---|
| AstraZeneca UK Ltd | Fluenz® | LAIV (live attenuated influenza vaccine) supplied as nasal spray suspension, egg-cultured | From 24 months to less than 18 years of age | Less than 0.024 micrograms per 0.2 ml dose | 0845 139 0000 |
| Sanofi | Vaxigrip | Inactivated influenza vaccine, split virion, egg cultured | From 6 months | Equal to or less than 0.05 micrograms per 0.5 ml dose | 0800 854 430 |
| Viatris | Influvac® sub-unit TIV▼ | Inactivated influenza vaccine, surface antigen, egg cultured | From 6 months | Equal to or less than 0.1 micrograms per 0.5 ml dose | 0800 358 7468 |
| CSL Seqirus UK | Cell-based Trivalent Influenza Vaccine Seqirus▼ | Inactivated influenza vaccine surface antigen, cell cultured | From 6 months | Egg-free | 0345 0093 804 |
| Sanofi | Supemtek TIVr▼ | Inactivated influenza vaccine, recombinant, cell cultured | From 18 years | None | 0800 854 430 |
| Sanofi | Efluelda TIV-HD▼ | Inactivated influenza vaccine, split virion, 60 micrograms HA/strain, egg cultured | From 60 years | Equal to or less than 1 microgram per 0.5ml dose | 0800 854 430 |
| CSL Seqirus UK | Adjuvanted Trivalent Influenza Vaccine Seqirus ▼ | Inactivated influenza vaccine surface antigen, adjuvanted with MF59C.1, egg cultured | From 50 years | Equal to or less than 1 microgram per 0.5ml dose | 0345 0093 804 |
This table was updated on 6 June 2025.
-
All vaccines marketed for the 2025 to 2026 season are trivalent. ↩